Phibro Animal Health Corp. (PAHC) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arbutus Biopharma Corp.

Arcutis Biotherapeutics, Inc.

Soleno Therapeutics, Inc.

Phibro Animal Health Corp.

Coherus BioSciences, Inc.

MacroGenics, Inc.

Nurix Therapeutics, Inc.

EyePoint Pharmaceuticals, Inc.

Erasca, Inc.

KalVista Pharmaceuticals, Inc.

Oric Pharmaceuticals, Inc.

Why is Phibro Animal Health Corp. ?

Poor long term growth as Operating profit has grown by an annual rate 17.48% of over the last 5 years

The company has declared Positive results for the last 6 consecutive quarters

NET PROFIT(HY) At USD 56.45 MM has Grown at 108.6%
ROCE(HY) Highest at 30.34%
RAW MATERIAL COST(Y) Fallen by -7.2% (YoY)

With ROCE of 17.46%, it has a attractive valuation with a 2.86 Enterprise value to Capital Employed

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 32.93%, its profits have risen by 574.3% ; the PEG ratio of the company is 0

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Consistent Returns over the last 3 years

Along with generating 32.93% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Phibro Animal Health Corp. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Phibro Animal Health Corp. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Phibro Animal Health Corp.

30.11%

1.49

59.24%

S&P 500

25.22%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.91%

EBIT Growth (5y)

17.48%

EBIT to Interest (avg)

4.29

Debt to EBITDA (avg)

3.40

Net Debt to Equity (avg)

2.50

Sales to Capital Employed (avg)

1.29

Tax Ratio

37.11%

Dividend Payout Ratio

40.46%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

12.74%

ROE (avg)

15.62%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.58

EV to EBIT

16.37

EV to EBITDA

12.67

EV to Capital Employed

2.86

EV to Sales

1.95

PEG Ratio

0.04

Dividend Yield

0.89%

ROCE (Latest)

17.46%

ROE (Latest)

29.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

NET PROFIT(HY)

At USD 56.45 MM has Grown at 108.6%

ROCE(HY)

Highest at 30.34%

RAW MATERIAL COST(Y)

Fallen by -7.2% (YoY

NET SALES(Q)

Highest at USD 383.54 MM

-4What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD 66.13 MM

DIVIDEND PAYOUT RATIO(Y)

Lowest at 20.5%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.06 times

Here's what is working for Phibro Animal Health Corp.

Net Profit

At USD 56.45 MM has Grown at 108.6%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales

Highest at USD 383.54 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost

Fallen by -7.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Phibro Animal Health Corp.

Operating Cash Flow

Lowest at USD 66.13 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Lowest at 2.06 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Dividend Payout Ratio

Lowest at 20.5%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)